Rivastigmine Tartrate (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Rivastigmine Tartrate drug offered from Actavis Pharma, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Rivastigmine Tartrate |
SUBSTANCE NAME: | RIVASTIGMINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-07-01 |
END MARKETING DATE: | 0000-00-00 |
Rivastigmine Tartrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Rivastigmine Tartrate from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.5(mg/1) |
START MARKETING DATE: | 2010-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-3208_931eef67-d110-4861-83d0-c698a7098485 |
PRODUCT NDC: | 0591-3208 |
APPLICATION NUMBER: | ANDA077129 |
Other RIVASTIGMINE TARTRATE Pharmaceutical Manufacturers / Labelers: